Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2008 1
2019 1
2020 4
2021 7
2022 8
2023 8
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

30 results

Results by year

Filters applied: . Clear all
Page 1
Immunogenicity Assessment of the SARS-CoV-2 Protein Subunit Recombinant Vaccine (CoV2-IB 0322) in a Substudy of a Phase 3 Trial in Indonesia.
Shakinah S, Aini MH, Sekartini R, Soedjatmiko, Medise BE, Gunardi H, Yuniar I, Indawati W, Koesnoe S, Harimurti K, Maria S, Wirahmadi A, Sari RM, Setyaningsih L, Surachman F. Shakinah S, et al. Among authors: koesnoe s. Vaccines (Basel). 2024 Apr 1;12(4):371. doi: 10.3390/vaccines12040371. Vaccines (Basel). 2024. PMID: 38675753 Free PMC article.
Consensus Guidelines for Influenza Vaccination in Patients with Diabetes.
Koesnoe S, Hasibuan AS, Suastika K, Kartasasmita C, Aman AM, Kshanti IA, Wisnu W, Djauzi S, Rengganis I, Widhani A, Maria S, Winulyo EB, Irawan H, Nugroho H, Soetedjo N, Adi S, Zufry H, Gita N. Koesnoe S, et al. Acta Med Indones. 2024 Jan;56(1):126-133. Acta Med Indones. 2024. PMID: 38561880 Free article.
A phase II clinical trial of a Vi-DT typhoid conjugate vaccine in healthy Indonesian adolescents and adults: one-month evaluation of safety and immunogenicity.
Koesnoe S, Medise BE, Rengganis I, Hadinegoro SR, Puspita M, Sari RM, Yang JS, Sahastrabuddhe S, Soedjatmiko, Gunardi H, Sekartini R, Wirahmadi A, Kekalih A, Mukhi S, Satari HI, Bachtiar NS. Koesnoe S, et al. Trop Dis Travel Med Vaccines. 2024 Feb 1;10(1):3. doi: 10.1186/s40794-023-00210-z. Trop Dis Travel Med Vaccines. 2024. PMID: 38297337 Free PMC article.
Incidence and Associated Factors of SARS-CoV-2 Infection Post-mRNA-1273 Booster Vaccination in Health-Care Workers.
Hasibuan AS, Koesnoe S, Widhani A, Muhadi M, Shatri H, Ginanjar E, Yunihastuti E, Soewondo P, Aman Nasution S, Djauzi S, Dina Liastuti L, Koento T, Sumariyono S, Mulyantini A. Hasibuan AS, et al. Among authors: koesnoe s. Vaccines (Basel). 2023 Feb 19;11(2):481. doi: 10.3390/vaccines11020481. Vaccines (Basel). 2023. PMID: 36851358 Free PMC article.
COVID-19 Vaccination Intention in Patients with Autoimmune Diseases in Indonesia: An Application of the Integrated Behavioural Model.
Widhani A, Pelupessy DC, Siddiq TH, Koesnoe S, Maria S, Yunihastuti E, Awanis GS, Karjadi TH, Hasibuan AS, Sukmana N, Hakam M, Putri KQ, Taufik IN, Widiyanti D, Rengganis I, Djauzi S. Widhani A, et al. Among authors: koesnoe s. Trop Med Infect Dis. 2023 Feb 9;8(2):109. doi: 10.3390/tropicalmed8020109. Trop Med Infect Dis. 2023. PMID: 36828525 Free PMC article.
30 results